PAI-1 affects vascular integrity

July 2009
Cardiology Today;Jul2009, Vol. 12 Issue 7, p9
The article discusses the role of obesity in increasing plasminogen activator inhibitor-1 (PAI-1), a predictor of myocardial infarction (MI), stroke and diabetes.


Related Articles

  • Obesity and Breast Cancer: The Roles of Peroxisome Proliferator-Activated Receptor-? and Plasminogen Activator Inhibitor-1. Carter, Jennifer C.; Church, Frank C. // PPAR Research;2009, Special section p1 

    Breast cancer is the most prominent cancer among females in the United States. There are a number of risk factors associated with development of breast cancer, including consumption of a high-fat diet and obesity. Plasminogen activator inhibitor-1 (PAI-1) is a cytokine upregulated in obesity...

  • Alterations in the Common Pathway of Coagulation During Weight Loss Induced by Gastric Bypass in Severely Obese Patients. Pardina, Eva; Ferrer, Roser; Rivero, Joaquín; Baena-Fustegueras, Juan A.; Lecube, Albert; Fort, Jose M.; Vargas, Víctor; Catalán, Roberto; Peinado-Onsurbe, Julia // Obesity (19307381);May2012, Vol. 20 Issue 5, p1048 

    The objective of this study was to establish the relationship between the plasminogen activator inhibitor-1 (PAI-1), antithrombin-III (ATIII), fibrinogen, and white blood cell (WBC) levels in severely obese patients. We analyzed various plasma parameters implicated in the intrinsic and extrinsic...

  • Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. Michihiro Mutoh; Naoko Niho; Masami Komiya; Mami Takahashi; Rina Ohtsubo; Kiyoshi Nakatogawa; Kentaro Ueda; Takashi Sugimura; Keiji Wakabayashi // Carcinogenesis;Apr2008, Vol. 29 Issue 4, p824 

    Obesity and hyperlipidemia are known to increase colorectal tumor risk. We noticed that Min mice, featuring a defect in the adenomatous polyposis coli (Apc) gene, develop intestinal polyps along with high serum triglyceride (TG) levels up to 10-fold those observed in wild-type mice. In these...

  • Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women. Solano, M P; Perry, A C; Wang, X; Ross, R; Goldberg, R B // International Journal of Obesity & Related Metabolic Disorders;Jan2003, Vol. 27 Issue 1, p82 

    OBJECTIVE: To compare plasma plasminogen activator inhibitor type 1 (PAI-1) levels and to examine the association of PAI-1 with visceral adiposity and other components of the metabolic syndrome in overweight and obese premenopausal African-American (AA) and Caucasian (CC) women. DESIGN:...

  • Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Ma, Li-Jun; Mao, Su-Li; Taylor, Kevin L.; Kanjanabuch, Talerngsak; Guan, YouFei; Zhang, YaHua; Brown, Nancy J.; Swift, Larry L.; McGuinness, Owen P.; Wasserman, David H.; Vaughan, Douglas E.; Fogo, Agnes B. // Diabetes;Feb2004, Vol. 53 Issue 2, p336 

    Increased plasminogen activator inhibitor 1 (PAI-1) has been linked to not only thrombosis and fibrosis but also to obesity and insulin resistance. Increased PAI-1 levels have been presumed to be consequent to obesity. We investigated the interrelationships of PAI-1, obesity, and insulin...

  • Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes. Kahn, Steven E.; Zinman, Bernard; Haffner, Steven M.; O'Neill, M. Colleen; Kravitz, Barbara G.; Yu, Dahong; Freed, Martin I.; Herman, William H.; Holman, Rury R.; Jones, Nigel P.; Lachin, John M.; Viberti, Giancarlo C. // Diabetes;Aug2006, Vol. 55 Issue 8, p2357 

    The inflammatory factor C-reactive protein (CRP) and the fibrinolytic variables fibrinogen and plasminogen activator-1 (PAI-1) are associated with long-term cardiovascular morbidity. To determine the contribution of body adiposity (BMI), insulin sensitivity (homeostasis model assessment of...

  • 4G/5G polymorphism modulates PAI-1 circulating levels in obese women. Fernandes, Karla; Sandrim, Valéria // Molecular & Cellular Biochemistry;May2012, Vol. 364 Issue 1/2, p299 

    The increase in plasminogen activator inhibitor type 1 (PAI-1) has been described as a risk factor to thrombosis-related diseases. In addition, it has been demonstrated that the variant 4G of polymorphism 4G/5G located in promoter region of PAI-1 gene is associated with higher PAI-1 levels. We...

  • The common -675 4G/5G polymorphism in the plasminogen activator inhibitor —1 gene is strongly associated with obesity. Hoffstedt, J.; Andersson, I.-L.; Persson, L.; Isaksson, B.; Arner, P. // Diabetologia;Apr2002, Vol. 45 Issue 4, p584 

    Aims/hypothesis. Plasminogen activator inhibitor 1 (PAI-1) increases in several insulin-resistant conditions such as obesity. We tested the hypothesis that the PAI-1 gene might be a candidate for obesity and Type II (non-insulin-dependent) diabetes mellitus. Methods. We investigated the...

  • Effects of Aerobic Fitness and Adiposity on Coagulation Biomarkers in Men vs. Women with Elevated Blood Pressure. Wilson, Kathleen L.; Tomfohr, Lianne; Edwards, Kate; Knott, Cindy; Hong, R. D. Suzi; Redwine, Laura; Calfas, Karen; Rock, Cheryl L.; von Känel, Roland; Mills, Paul J. // European Journal of Cardiovascular Medicine;2012, Vol. 2 Issue 2, p122 

    A hypercoagulable state is a potential mechanism linking elevated blood pressure (BP), adiposity and a sedentary lifestyle to development of coronary heart disease (CHD). We examined relationships among aerobic fitness and adiposity in 76 sedentary subjects with elevated BP. Blood levels of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics